- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT05013151
The Effect of Dates and Castor Oil on the Initiation of Spontaneous Labor in Primigravida Parturients
August 18, 2021 updated by: Nir Kugelman, Carmel Medical Center
The Effect of Dates and Castor Oil on the Initiation of Spontaneous Labor in Primigravida Parturients- a Prospective Randomized Trial
Finding a natural and efficient method to improve the chance of entering spontaneous labor beyond 39 weeks of gestation will address both the medical necessity and the will of many parturients to avoid medical interventions.
In this study we aim to evaluate the effect of dates and castor oil on the initiation of spontaneous labor in primigravida parturients.
Study Overview
Status
Not yet recruiting
Intervention / Treatment
Study Type
Interventional
Enrollment (Anticipated)
450
Phase
- Not Applicable
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Contact
- Name: Nir Kugelman, MD
- Phone Number: 972-546830804
- Email: nirkug@gmail.com
Study Locations
-
-
-
Haifa, Israel
- Carmel Medical Center
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
18 years to 45 years (Adult)
Accepts Healthy Volunteers
Yes
Genders Eligible for Study
Female
Description
Inclusion Criteria:
- Pregnant women who come to the obstetrical emergency department for normal check up between 39+4 and 40+2 weeks of gestation
- Primipara
- Bishop cervical score below 5
- Low risk pregnancy
- Singleton pregnancy
- Vertex presentation
- Women who haven't consumed dates over once a week in month prior the checkup and haven't consumed castor oil prior to enrollment.
Exclusion Criteria:
- Any medical indication for labor induction
- Regular contractions
- Premature rupture of membranes
- Women who consumed dates over once a week in month prior the checkup or consumed castor oil prior to enrollment.
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: Treatment
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: None (Open Label)
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
No Intervention: Control Group
|
|
|
Experimental: Date consumption
Consumption of 6 dates a day until 41 weeks of gestation
|
Consumption of 6 dates a days until 41 weeks of gestation
|
|
Experimental: Castor oil consumption
One time consumption of 60 CC of Castor oil
|
One time consumption of 60 CC Castor oil
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Rates of spontaneous entry into labor
Time Frame: 2 weeks after enrollment
|
Rate of women who will enter labor spontaneously without intervention
|
2 weeks after enrollment
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Cervical ripening- Bishop score
Time Frame: 2 weeks after enrollment
|
Change of cervical ripening status after intervention
|
2 weeks after enrollment
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Sponsor
Investigators
- Study Director: Lena Sagi-Dain, MD, Lady Davis Carmel Medical Center
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start (Anticipated)
August 24, 2021
Primary Completion (Anticipated)
January 30, 2022
Study Completion (Anticipated)
February 28, 2022
Study Registration Dates
First Submitted
August 17, 2021
First Submitted That Met QC Criteria
August 18, 2021
First Posted (Actual)
August 19, 2021
Study Record Updates
Last Update Posted (Actual)
August 19, 2021
Last Update Submitted That Met QC Criteria
August 18, 2021
Last Verified
August 1, 2021
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- CMC-21-0064-CTIL
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
NO
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
No
Studies a U.S. FDA-regulated device product
No
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.